AI assistant
MEDIFAST INC — Director's Dealing 2024
Jun 24, 2024
33899_dirs_2024-06-24_3d010930-b670-4a11-bffc-1d1f25932fd4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2024-06-20
Reporting Person: Xian Ming (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-06-20 | Restricted Stock Units (cash settled) | $ | A | 10149 | Acquired | Common Stock (10149) | Direct |
Footnotes
F1: Represents the contingent right to receive 10,149 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.